How we prove a zinc bisglycinate lot is the chelate, not a blend
A zinc bisglycinate lot can be called the chelate only when four things agree: the 1:2 zinc–glycine form, the ligand ratio measured on that lot, the crystal evidence, and a composition that discloses everything in the drum. The zinc assay answers one part of one question. Glycine, free glycine, XRD and FTIR are what close the rest.
A zinc number is not an identity. The form, the ligand ratio and the crystal evidence have to agree before the lot can be called the chelate.
The four layers
Layer one is what the molecule is: a monohydrate of the 1:2 zinc–glycine chelate, not an oxide, carbonate, sulfate or gluconate. Layer two is stoichiometry: two ligand molecules for every zinc, measured on the lot in question. Layer three is the solid state: the hydrate and the presence or absence of crystalline zinc oxide. Layer four is disclosure: nothing else in the drum — carrier, second zinc source, residual solvent — that the paperwork omits.
These are separate questions for a reason. One laboratory result can close one layer and leave the other three open.
The ratio is the simplest check
One zinc, two glycines, one water: that is the monohydrate. The zinc titration counts the metal; the glycine HPLC counts the ligand. Divide the molar amount of glycine by the molar amount of zinc, and a true 1:2 material lands near 2.00. The released range of 1.95–2.05 exists to absorb method variation, not to accommodate a different molecule.
A calculated number inherits the errors of both inputs, and it also inherits their bases. Zinc reported as-is cannot be paired with glycine reported on a dried basis. Free glycine is the other half of the ligand picture: total glycine counts both bound and unbound, so a high total with a high free figure means extra glycine was added, not that more chelate is present. Conversely, normal zinc with low glycine suggests a second zinc source or a carrier.
That is why a specification needs zinc, glycine and free glycine as three separate lines, with the ratio as the arithmetic that connects them.
XRD, FTIR and the crystal form
| Method | What it establishes | Where it stops |
|---|---|---|
| EDTA titration | Total zinc in the sample | Does not identify the ligand or the counter-ion |
| Glycine HPLC | Total glycine | Bound and free glycine are not separated |
| Zn : glycine calculation | Agreement with 1:2 stoichiometry | Cannot exclude a second zinc source by itself |
| X-ray diffraction | Crystalline zinc oxide above the reported limit | Blind to amorphous or dissolved species |
| FTIR | Glycine–zinc coordination | Does not give blend percentages |
| Loss on drying / TGA | Water and hydrate behaviour | Cannot resolve a mixed hydrate |
For crystalline zinc oxide, XRD is the most direct evidence available. Its value depends on the detection limit, which varies with instrument and preparation, so a report that says “absent” without a limit does not answer the question. FTIR looks at the same sample from the ligand side: the spectrum of a reacted chelate differs from that of a dry mix of oxide and chelate. Neither test replaces the other, and a chelate claim is strongest when both are on file.
XRD can also reveal crystalline chelate phases, which helps with hydrate identification. It will not quantify an amorphous second source, so the elemental and ligand assays remain in the set.
The adulteration routes
A common substitution is zinc oxide. It lifts the elemental figure, reduces the chelate share of the drum and often improves flow. The zinc result can pass while the ratio drifts, and XRD may find crystalline oxide. A different zinc salt changes solubility and pH as well as the ratio. Added glycine lifts both total and free glycine and can mask the ratio if only the total is read. A hydrate switch keeps the same molecule but changes the zinc per gram, which shows up in LOD and assay together. A carrier dilutes both zinc and glycine and may leave the ratio untouched.
No single test covers all five. The release set has to combine the elemental assay, the ligand assay, the free-ligand figure and at least one solid-state method, so a lot that passes zinc but fails the ligand cannot be released.
What to write into the specification
- “Zinc bisglycinate monohydrate, 1:2 chelate; no added zinc oxide.”
- “Zinc 26.0–28.0% by complexometric EDTA; glycine 59.5–64.5% by HPLC, with the basis stated.”
- “Zn : glycine 1.95–2.05; free glycine ≤1.0%.”
- “Loss on drying ≤8.0%; hydrate named on the certificate.”
- “Particle size ≥95% through 40 mesh; bulk density 0.40–0.70 g/mL.”
- “XRD: no crystalline zinc oxide detected, with the detection limit reported; FTIR coordination on request.”
The clause that matters most is the one about added oxide. If the material is blended after the chelate is made, the blender owns the blend and should issue the certificate; the chelate maker's COA no longer describes the drum.
What to ask the supplier
- Is the lot one chelate, or a blend? If blended, what is in it and in what proportion?
- What zinc and glycine results belong to this lot, and on what basis was each reported?
- What ratio do those results calculate to, and what is the free-glycine figure?
- Does an XRD report cover crystalline zinc oxide, and what limit does it quote? Is there an FTIR spectrum?
- Which hydrate is declared, and is any carrier or second zinc source present?
Five clear answers amount to a specification. A single zinc percentage does not. The COA page shows where the results sit on the certificate; the grade page works through the hydrate arithmetic; the blend question is handled on the oxide versus bisglycinate page; the XRD note and FTIR note describe the methods; the product hub carries the specification.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation